Financhill
Buy
68

ARQT Quote, Financials, Valuation and Earnings

Last price:
$29.31
Seasonality move :
61.76%
Day range:
$29.28 - $30.26
52-week range:
$11.13 - $31.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.77x
P/B ratio:
22.71x
Volume:
2.2M
Avg. volume:
2.4M
1-year change:
95.79%
Market cap:
$3.6B
Revenue:
$196.5M
EPS (TTM):
-$0.35

ARQT Analysts' Consensus Rating

The 6 analysts providing 12-month price projections for Arcutis Biotherapeutics, Inc. shares anticipate an average target of $31.63, ranging from a low estimate of $29.00 to a high estimate of $37.00. This average target implies a growth of 5.77% compared to the current stock price of $29.31.

Consensus Price Target

$31.63

Highest Price Target

$37.00

Lowest Price Target

$29.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 4 5 5

Hold 0 1 1

Sell 0 0 0
Consensus Buy Buy Buy

ARQT Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 23

Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 4.13% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is up 12.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock